May 2025 - Pharmaceutical Market Europe

May 2025 - Pharmaceutical Market Europe
Published on 20 May 2025

Description:

Rising to meet the challenges of clinical trials; Accelerating access to rare disease treatments; Maximising the potential of AI in pharma

Preview:

46 articles from this collection:
PME May 2025
PME May 2025
2 PME
2 PME
3 Comment
3 Comment
4 Communique Awards 2025
4 Communique Awards 2025
5 Contents
5 Contents
6-7 News
6-7 News
Roche and Ascidian agree to $1.8bn neurological disease partnership
8-9 News
8-9 News
Researchers identify new major cause of inflammatory bowel disease
10-11 Dermatology News
10-11 Dermatology News
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
12 DARWIN'S MEDICINE - DARWIN’S DICTUM ON DATA
12 DARWIN'S MEDICINE - DARWIN’S DICTUM ON DATA
The evolutionary lessons for Bayer’s management restructure
13 MIKE DIXON - Patient partnerships for life
13 MIKE DIXON - Patient partnerships for life
Collecting the right data in the right way for the right reasons
14 INNOVATIVE IMPACT BLOG - LOCAL MUSCLE, GLOBAL IMPACT
14 INNOVATIVE IMPACT BLOG - LOCAL MUSCLE, GLOBAL IMPACT
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
15 Bridging the gap: from awareness to action in health equity
15 Bridging the gap: from awareness to action in health equity
16-17 FUTURE OF CANCER CARE - Shaping the future of cancer care
16-17 FUTURE OF CANCER CARE - Shaping the future of cancer care
Across almost every sector, brands are multiplying their investment in creativity
18-19 RARE DISEASE RESEARCH - Better together –  accelerating innovation and access
18-19 RARE DISEASE RESEARCH - Better together – accelerating innovation and access
20-21 DUCHENNE MUSCULAR DYSTROPHY - Duchenne muscular dystrophy – diagnosis, clinical development
20-21 DUCHENNE MUSCULAR DYSTROPHY - Duchenne muscular dystrophy – diagnosis, clinical development
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
22 TL CAMINO - Exploring AI in pharma: how can we achieve lift-off?
22 TL CAMINO - Exploring AI in pharma: how can we achieve lift-off?
Picking your omnichannel direction requires a disciplined, scientific approach
23 PME highlights
23 PME highlights
24 TL VEEVA - The future of customer engagement in biopharma
24 TL VEEVA - The future of customer engagement in biopharma
25 Communications Excellence cover
25 Communications Excellence cover
26 TRENDS: 67 Health
26 TRENDS: 67 Health
26 TRENDS: akt health
26 TRENDS: akt health
27 TRENDS: arc bio
27 TRENDS: arc bio
27 TRENDS: aurora
27 TRENDS: aurora
28 TRENDS: Bedrock
28 TRENDS: Bedrock
28 TRENDS: Edelman
28 TRENDS: Edelman
29 TRENDS: HCG
29 TRENDS: HCG
29 TRENDS: Incisive Health
29 TRENDS: Incisive Health
30 TRENDS: IPG Health
30 TRENDS: IPG Health
30 TRENDS: Langland
30 TRENDS: Langland
31 TRENDS: M+F Health
31 TRENDS: M+F Health
31 TRENDS: Open Health
31 TRENDS: Open Health
32 TRENDS: Real Chemistry
32 TRENDS: Real Chemistry
32 TRENDS: SAY
32 TRENDS: SAY
33 TRENDS: Virgo Health
33 TRENDS: Virgo Health
33 Communique 26
33 Communique 26
34-35 CLINICAL TRIALS – overcoming the barriers to improved enrolment and retention
34-35 CLINICAL TRIALS – overcoming the barriers to improved enrolment and retention
37 TL PERSONIA HEALTH - Improving engagement with clinical trials: time to apply behavioural science
37 TL PERSONIA HEALTH - Improving engagement with clinical trials: time to apply behavioural science
38-39 WOMEN IN CLINICAL TRIALS - Achieving gender parity – designing clinical trials with women in
38-39 WOMEN IN CLINICAL TRIALS - Achieving gender parity – designing clinical trials with women in
40-41 AI IN PHARMA - Maximising the potential of AI in pharma
40-41 AI IN PHARMA - Maximising the potential of AI in pharma
42 BRUNTWOOD SCITECH – University healthcare training centre to open at Bruntwood SciTech
42 BRUNTWOOD SCITECH – University healthcare training centre to open at Bruntwood SciTech
‘Patient engagement is both a process and a behaviour throughout the drug life cycle’
43 PharmaRole
43 PharmaRole
44 Appointments
44 Appointments
45 Appointments
45 Appointments
46 Appointments
46 Appointments
47 - HEALTHCRAE COMMS
47 - HEALTHCRAE COMMS
40 FlyPharma Amsterdam 2025
40 FlyPharma Amsterdam 2025